Sensorimotor rhythm neurofeedback as an adjuct therapy for Parkinson's Disease
9 August 2017
Despite all the research effort to target neurodegeneration, there is still a lack of satisfactory drug-mediated treatments for Parkinson´s disease. Therefore, there is an urgent need for new treatment modalities such as neurofeedback technology that target diseases of the brain. Neurofeedback is based on neurological compensatory mechanisms that help our brain to adjust to ever-changing conditions, including Parkinson´s disease.
In a standardized controlled study in parkinsonian marmosets we have shown that the non-invasive EEG-based sensorimotor rhythm (SMR) neurofeedback training results in a less progression of the disease and improves the therapeutic efficacy of the classical L-DOPA treatment, indicating that SMR neurofeedback, as an adjunct therapy, may allow for lesser dosages of L-DOPA, which will limit aversive side effects. This is an important indication of the therapeutic power of SMR neurofeedback as a joint strategy for minimization of disability and improvement of the quality of life. This work was published in the scientific journal Annals of Clinical and Translational Neurology